Task: Answer the multiple choice question.
Query: Which compound exhibits a -32.206% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CCc1ccccc1NC(=O)NNC(=O)CCc1ccc(OC)cc1
b. COc1ccc(OCc2cc(C(=O)N(C)C3CCOCC3)no2)c2ccccc12
c. O=C(NC(Cc1ccccc1)C(=O)O)/C(=C/c1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1Br
d. CCN1CCN(c2nc(Nc3ccc(OC)cc3)nc(N)c2[N+](=O)[O-])CC1
Answer: d. CCN1CCN(c2nc(Nc3ccc(OC)cc3)nc(N)c2[N+](=O)[O-])CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2nc(Nc3ccc(OC)cc3)nc(N)c2[N+](=O)[O-])CC1
CCN1CCN(c2nc(Nc3ccc(OC)cc3)nc(N)c2[N+](=O)[O-])CC1
[4-amino-6-(4-ethylpiperazin-1-yl)-2-(4-methoxyanilino)pyrimidin-5-yl]-oxido-oxoazanium